ClinConnect ClinConnect Logo
Search / Trial NCT02406053

Oxidative Damage and Antioxidant Mechanisms in COPD

Launched by YUZUNCU YIL UNIVERSITY · Mar 27, 2015

Trial Information

Current as of June 23, 2025

Completed

Keywords

Lung Cancer Antioxidants Oxidative Damage

ClinConnect Summary

Introduction Lung is a particularly important organ because of its interface with the environment. The environmental pollutants and endogenous reactive oxygen metabolites from inflammatory cells exert substantial pathological effects on the lung cells \[1\]. Oxidative stress (OS) is a major factor that plays a significant role in lung cancer (LC) \[2\], chronic obstructive pulmonary disease (COPD) \[3\] and obstructive sleep apnea syndrome (OSAS) \[4, 5\]. The current evidence suggests that OS takes part in the mechanisms involved in initiation, promotion and progression of respiratory dise...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Malondialdehyde (MDA), 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-OHdG), and coenzyme Q10 (CoQ10) levels were evaluated in the blood samples of patients with COPD, LC, and OSAS by high-pressure liquid chromatography method.
  • Exclusion Criteria:
  • The diagnosis of lung cancer was based on the analysis of biopsy or cytologic specimens obtained by bronchoscopic examination, transthoracic biopsy or surgery. The patients Who hadn't have chemo or/and radiotherapy were included to the study.
  • The exclusion criteria for COPD, OSAS and lung cancer were the presence of the following: history of cardiovascular disease, hypertension, diabetes mellitus, inflammatory or infectious.

About Yuzuncu Yıl University

Yüzüncü Yıl University is a distinguished institution committed to advancing healthcare through rigorous clinical research. With a strong emphasis on innovation and collaboration, the university actively engages in various clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Its dedicated research teams are equipped with state-of-the-art facilities and a diverse array of expertise, fostering an environment that promotes ethical standards and scientific excellence. Yüzüncü Yıl University is dedicated to contributing to the global medical community by translating research findings into practical applications for improved health and well-being.

Locations

Patients applied

0 patients applied

Trial Officials

AYSEL SUNNETCIOGLU, Phd

Principal Investigator

Yuzuncu Yıl University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials